X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1865) 1865
pyridazines - therapeutic use (1717) 1717
science & technology (1461) 1461
life sciences & biomedicine (1420) 1420
male (1157) 1157
female (962) 962
pyridazines - pharmacology (744) 744
animals (718) 718
middle aged (675) 675
hydrazones - therapeutic use (596) 596
cardiotonic agents - therapeutic use (542) 542
adult (530) 530
pharmacology & pharmacy (486) 486
aged (424) 424
pyridazines - administration & dosage (407) 407
heart failure - drug therapy (389) 389
treatment outcome (383) 383
cardiovascular system & cardiology (335) 335
pyridazines - adverse effects (327) 327
cardiac & cardiovascular systems (314) 314
levosimendan (295) 295
hiv infections - drug therapy (224) 224
heart failure (221) 221
rats (221) 221
abridged index medicus (215) 215
hemodynamics - drug effects (201) 201
double-blind method (194) 194
hydrazones - pharmacology (194) 194
vasodilator agents - therapeutic use (193) 193
pyridazines - pharmacokinetics (186) 186
blood pressure - drug effects (185) 185
dose-response relationship, drug (183) 183
mice (182) 182
cardiotonic agents - pharmacology (167) 167
drug therapy, combination (166) 166
time factors (160) 160
drug therapy (154) 154
hypertension - drug therapy (152) 152
general & internal medicine (151) 151
adolescent (150) 150
research (148) 148
hypertension, pulmonary - drug therapy (146) 146
heart failure - physiopathology (144) 144
analysis (143) 143
clinical trials as topic (143) 143
hydrazones - administration & dosage (141) 141
imidazoles - therapeutic use (137) 137
anti-hiv agents - therapeutic use (136) 136
pyridazines - chemistry (130) 130
antihypertensive agents - therapeutic use (129) 129
care and treatment (129) 129
oncology (125) 125
phenylpropionates - therapeutic use (125) 125
medicine & public health (120) 120
infectious diseases (118) 118
cardiotonic agents - administration & dosage (116) 116
reverse transcriptase inhibitors - therapeutic use (116) 116
heart rate - drug effects (113) 113
mutation (112) 112
protein kinase inhibitors - therapeutic use (109) 109
randomized controlled trials as topic (108) 108
health aspects (107) 107
angiotensin-converting enzyme inhibitors - therapeutic use (102) 102
disease models, animal (100) 100
sulfonamides - therapeutic use (99) 99
antineoplastic agents - therapeutic use (98) 98
hiv-1 - drug effects (97) 97
young adult (95) 95
infusions, intravenous (93) 93
prospective studies (93) 93
dogs (92) 92
etravirine (92) 92
anesthesiology (91) 91
drug interactions (91) 91
dobutamine - therapeutic use (90) 90
cilazapril (88) 88
administration, oral (86) 86
neurosciences & neurology (86) 86
pulmonary hypertension (86) 86
acute disease (85) 85
hiv infections - virology (85) 85
imidazoles - pharmacology (85) 85
myocardial contraction - drug effects (85) 85
critical care medicine (84) 84
simendan (81) 81
cardiology (80) 80
clinical trials (80) 80
mortality (80) 80
dosage and administration (79) 79
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (79) 79
neurosciences (78) 78
protein kinase inhibitors - pharmacology (78) 78
pyridazines (78) 78
retrospective studies (78) 78
cardiac patients (77) 77
hypertension (77) 77
vasodilator agents - pharmacology (76) 76
respiratory system (74) 74
cardiotonic agents - adverse effects (73) 73
immunology (73) 73
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2144) 2144
German (59) 59
Japanese (57) 57
Spanish (44) 44
French (36) 36
Italian (34) 34
Russian (24) 24
Chinese (13) 13
Portuguese (11) 11
Polish (4) 4
Norwegian (3) 3
Romanian (2) 2
Serbian (2) 2
Turkish (2) 2
Croatian (1) 1
Czech (1) 1
Danish (1) 1
Finnish (1) 1
Lithuanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Current medicinal chemistry, ISSN 0929-8673, 2017, Volume 24, Issue 16, pp. 1 - 16
... the most clinically practiced therapeutic approaches, the modulation of multiple proteins by a single drug, in accordance... 
Tumor microenvironment | Fda-Approved drugs | Multitargeted drugs | Anticancer agents | Polypharmacology | Tyrosine kinase receptors | Oncogene addiction | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Neoplasms - metabolism | Niacinamide - analogs & derivatives | Anilides - therapeutic use | Pyrazoles - therapeutic use | Pyridines - chemistry | Humans | Anilides - chemistry | Imidazoles - chemistry | Imatinib Mesylate - therapeutic use | Protein Kinase Inhibitors - chemistry | Pyrazoles - chemistry | Niacinamide - chemistry | Phenylurea Compounds - chemistry | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Imidazoles - therapeutic use | Pyrroles - therapeutic use | Quinazolines - chemistry | Pyridazines - therapeutic use | Pyridines - therapeutic use | Piperidines - chemistry | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Receptor Protein-Tyrosine Kinases - metabolism | Imatinib Mesylate - chemistry | Neoplasms - drug therapy | Pyridazines - chemistry | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Pyrroles - chemistry | Indoles - therapeutic use | Neoplasms - pathology | Indoles - chemistry | Tyrosine | Cell proliferation | Drugs | Medical research | Phenotypes | Clinical trials | Kinases | Proteins | Inhibitors | Modulation | Protein-tyrosine kinase | Deoxyribonucleic acid--DNA | Cancer
Journal Article
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2015, Volume 373, Issue 9, pp. 834 - 844
Journal Article
Clinics in perinatology, ISSN 0095-5108, 03/2012, Volume 39, Issue 1, pp. 221 - 238
Journal Article